Amphastar Pharmaceuticals: Q2 Earnings Insights

 

Amphastar Pharmaceuticals AMPH reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Amphastar Pharmaceuticals beat estimated earnings by 8.33%, reporting an EPS of $0.39 versus an estimate of $0.36.

Revenue was up $21.80 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 7.05% increase in the share price the next day.

Here's a look at Amphastar Pharmaceuticals's past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.36 0.37 0.24 0.21
EPS Actual 0.47 0.42 0.46 0.21
Revenue Estimate 113.33M 111.44M 103.24M 101.78M
Revenue Actual 120.37M 120.89M 112.20M 101.66M

To track all earnings releases for Amphastar Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMPH Logo
AMPHAmphastar Pharmaceuticals Inc
$25.991.84%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
11.82
Growth
53.65
Quality
41.73
Value
61.73
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...